Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Evolving views and practices of antiretroviral treatment prescribers in Australia

- Featured Image

The most recent Australian HIV clinical treatment guidelines support early antiretroviral treatment (ART) initiation, whereby asymptomatic patients should start treatment once their CD4+ cell count approaches 500 cells/mm3 or even earlier.1 This is consistent with a global movement based on emerging evidence and growing expert consensus that early initiation of ART has clear clinical benefits to individual patients and a potentially important population effect in reducing HIV transmission to patients’ uninfected sexual partners.2,3 Compared with earlier regimens, current ART regimens are less toxic, have simpler dosing requirements and lower pill burdens, and do not generally require as high a degree of drug adherence to achieve viral suppression.3 These developments have influenced policy regulation, resource allocation and ART initiation practices in Australia4,5 and other high-income countries.6,7

There is a paucity of research on prescriber characteristics relating to ART initiation practices. In some of the few studies that have been conducted, prescribers’ knowledge about ART guideline…

email